KRMD(KRMD)
KRMD
Next earnings: Aug 5, 2026 · After close
Signal
Bearish Setup2↓
PRICE
Prev Close
3.98
Open
3.92
Day Range3.87 – 4.00
3.87
4.00
52W Range2.63 – 6.61
2.63
6.61
32% of range
VOLUME & SIZE
Avg Volume
156.0K
FUNDAMENTALS
P/E Ratio
-78.0x
Not profitable
EPS (TTM)
—
Div Yield
No dividend
Beta
0.69
Low vol
Key MetricsTTM
Market Cap$179.14M
Revenue TTM$43.26M
Net Income TTM-$2.28M
Free Cash Flow$179.3K
Gross Margin61.5%
Net Margin-5.3%
Operating Margin-6.0%
Return on Equity-13.6%
Return on Assets-8.0%
Debt / Equity0.20
Current Ratio2.33
EPS TTM$-0.05
ANALYST COVERAGE5 analysts
BUY
▲ +79.5%upside to target
L $6.00
Med $7.00consensus
H $8.00Upcoming Events
EEarnings Report
Tomorrow
May 18
DEx-Dividend
In 89 days
Aug 14
PDividend Pay
In 103 days
Aug 28
KRMD News
About
Repro Med Systems, Inc. dba KORU Medical System develops, manufactures, and commercializes innovative and easy-to-use specialty infusion solutions that improve quality of life for patients around the world. The FREEDOM Syringe Infusion System currently includes the FREEDOM60® and FreedomEdge® Syringe Infusion Drivers, Precision Flow Rate Tubing™ and HIgH-Flo Subcutaneous Safety Needle Sets™. These devices are used for infusions administered in the home and alternate care settings.
Adam KalbermattenPresident & Chief Commercial Officer
Christopher PazdanChief Operating Officer
Eric SchillerChief Technology Officer
Thomas AdamsChief Financial Officer, Secretary & Treasurer
Linda TharbyCEO & Director